Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer

Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer

Non-small-cell lung cancer (NSCLC) patients who experience brain metastases are usually associated with poor prognostic outcomes. This retrospective study proposed to assess whether bevacizumab or gefitinib can be used to improve the effectiveness of whole brain radiotherapy (WBRT) in managing patie...

Full description

Bibliographic Details
Main Authors: R.F. Yang, B. Yu, R.Q. Zhang, X.H. Wang, C. Li, P. Wang, Y. Zhang, B. Han, X.X. Gao, L. Zhang, Z.M. Jiang
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2017-11-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Non-small-cell lung cancer
Brain metastasis
Bevacizumab
Gefitinib
Whole brain radiotherapy
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2018000100606&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2018000100606&lng=en&tlng=en

Similar Items